Metrion Biosciences Limited (“Metrion”), the specialist ion channel and cardiac safety screening contract research organization (CRO) and drug discovery company, and Enamine Ltd (“Enamine”), the ...

Scientists often turn to high throughput screening (HTS) to quickly assay large-scale compound libraries against a desired target, accelerating life science research. New technologies and relevant ...

The Echo® MS+ system unlocks enhanced high-throughput screening capability by bringing acoustic ejection mass spectrometry (AEMS) approaches to the SCIEX ZenoTOF 7600 system. FRAMINGHAM, ...

Metrion Biosciences ("Metrion"), the specialist preclinical contract research organization (CRO) and a global leader in ion channel services, today announced the launch of its validated, ...

To battle this epidemic, the National Institutes of Health (NIH) launched the Helping to End Addiction Long-term (HEAL) Initiative in 2018. As part of this effort, scientists at the NIH National ...

According to MarketsandMarkets™, the Drug Discovery Technologies Market is projected to grow from about USD 30.58 billion in ...

Autonomy, by contrast, is about decision‑making and adaptation. The leap from automation to autonomy is not just more actuators; it is a system that can perceive its environment, reason about options, ...

SCIEX launched the Echo ® MS+ system at SLAS 2024. According to the company, the system couples proprietary acoustic ejection mass spectrometry technology and open port interface (OPI) sampling with ...

CAMBRIDGE, England & KYIV, Ukraine--(BUSINESS WIRE)--Metrion Biosciences Limited (“Metrion”), the specialist ion channel and cardiac safety screening contract research organisation (CRO) and drug ...